The historical rank and industry rank for Enanta Pharmaceuticals's Pretax Margin % or its related term are showing as below:
ENTA'
s Pretax Margin % Range Over the Past 10 Years
Min: -178.25 Med: 24.21 Max: 77.98
Current: -178.25
ENTA's Pretax Margin % is ranked worse than 50.58% of 1032
companies
in the Biotechnology industry
Industry Median: -167.31
vs ENTA: -178.25
Enanta Pharmaceuticals Pretax Margin % Historical Data
The historical data trend for Enanta Pharmaceuticals's Pretax Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Enanta Pharmaceuticals's Pretax Margin %
For the Biotechnology subindustry, Enanta Pharmaceuticals's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Enanta Pharmaceuticals's Pretax Margin % Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Enanta Pharmaceuticals's Pretax Margin % distribution charts can be found below:
* The bar in red indicates where Enanta Pharmaceuticals's Pretax Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.
The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.
It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.
The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.
Enanta Pharmaceuticals Pretax Margin % Related Terms
Thank you for viewing the detailed overview of Enanta Pharmaceuticals's Pretax Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.
Enanta Pharmaceuticals (Enanta Pharmaceuticals) Business Description
Enanta Pharmaceuticals Inc is an American biotechnology company focused on the research and development of molecule drugs to cure viral infections and liver diseases. The targeted diseases are hepatitis C, hepatitis B, nonalcoholic steatohepatitis, and the respiratory syncytial virus. The novelty of company research is a specific direct-acting antiviral inhibitor against the hepatitis C virus. The company's inhibitors have been developed in collaboration with AbbVie. AbbVie markets the protease inhibitor, paritaprevir, while other inhibitors are in the pipeline.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
ENTA has been successfully added to your 